African ancestry and higher prevalence of triple-negative breast cancer: findings from an international study

Simple item page
dc.contributor.authorStark, A.
dc.contributor.authorKleer, C.G.
dc.contributor.authorMartin, I.
dc.contributor.authorAwuah, B.
dc.contributor.authorNsiah-Asare, A.
dc.contributor.authorTakyi, V.
dc.contributor.authorBraman, M.
dc.contributor.authorQuayson, S.E.
dc.date.accessioned2013-05-23T13:21:00Z
dc.date.accessioned2017-10-19T12:54:06Z
dc.date.available2013-05-23T13:21:00Z
dc.date.available2017-10-19T12:54:06Z
dc.date.issued2010
dc.description.abstractBACKGROUND The study of breast cancer in women with African ancestry offers the promise of identifying markers for risk assessment and treatment of triple-negative disease. METHODS African American and white American women with invasive cancer diagnosed at the Henry Ford Health System comprised the primary study population, and Ghanaian patients diagnosed and/or treated at the Komfo Anokye Teaching Hospital in Kumasi, Ghana constituted the comparison group. Formalin-fixed, paraffin-embedded specimens were transported to the University of Michigan for histopathology confirmation, and assessment of estrogen and progesterone receptors and HER-2/neu expression. RESULTS The study population included 1008 white Americans, 581 African Americans, and 75 Ghanaians. Mean age at diagnosis was 48.0 years for Ghanaian, 60.8 years for African American, and 62.4 for white American cases (P =.002). Proportions of Ghanaian, African American, and white American cases with estrogen receptor-negative tumors were 76%, 36%, and 22%, respectively (P < .001), and proportions with triple-negative disease were 82%, 26%, and 16%, respectively (P < .001). All Ghanaian cases were palpable, locally advanced cancers; 57 (76%) were grade 3. A total of 147 American women were diagnosed as stage III or IV; of these, 67.5% (n =46) of African Americans and 44.6% (n = 29) of white Americans were grade 3. Among palpable, grade 3 cancers, Ghanaians had the highest prevalence of triple-negative tumors (82.2%), followed by African Americans (32.8%) and white Americans (10.2%). CONCLUSIONS Our study demonstrates progressively increasing frequency of estrogen receptor-negative and triple-negative tumors among breast cancer patients with white American, African American, and Ghanaian/African backgrounds. This pattern indicates a need for additional investigations correlating the extent of African ancestry and high-risk breast cancer subtypesen_US
dc.identifier.citationStark, A., Kleer, C. G., Martin, I., Awuah, B., Nsiah-Asare, A., Takyi, V., Braman, M., Quayson, S. E. (2010). African ancestry and higher prevalence of triple-negative breast cancer: findings from an international study. Cancer,116(21), 4926-4932.en_US
dc.identifier.urihttp://197.255.68.203/handle/123456789/2867
dc.language.isoenen_US
dc.publisherCanceren_US
dc.subjectBreast canceren_US
dc.subjectTriple negativeen_US
dc.subjectRaceen_US
dc.subjectAfrican Americanen_US
dc.subjectWhite Americanen_US
dc.subjectAfrican ancestryen_US
dc.titleAfrican ancestry and higher prevalence of triple-negative breast cancer: findings from an international studyen_US
dc.typeArticleen_US

Files

Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
QUAYSON1.pdf
Size:
479.05 KB
Format:
Adobe Portable Document Format
Download
License bundle
Now showing 1 - 2 of 2
No Thumbnail Available
Name:
license.txt
Size:
1.82 KB
Format:
Item-specific license agreed upon to submission
Description:
Download
No Thumbnail Available
Name:
license.txt
Size:
0 B
Format:
Item-specific license agreed upon to submission
Description:
Download

Collections

Department of Pathology